SCHEMBL22240443

SCHEMBL22240443

CC(C)[C@H]1Cc2ccccc2N(C)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.46
MTNR1B P49286 1/20 0.46
PRKCG P05129 1/20 0.39
PRKCA P17252 1/20 0.39
PRKCD Q05655 1/20 0.39
OPRM1 P35372 4/20 0.38
OPRK1 P41145 4/20 0.38
OPRL1 P41146 3/20 0.38
OPRD1 P41143 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
SLC6A2 P23975 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
SLC6A4 P31645 1/20 0.38
ADRA1A P35348 1/20 0.38
HRH1 P35367 1/20 0.38
HTR2B P41595 1/20 0.38
KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10346329 1.00 MTNR1A (0.46) MTNR1AMTNR1BPRKCGPRKCAPRKCD
SCHEMBL22434211 0.81 OPRM1 (0.38) OPRM1OPRK1OPRL1OPRD1NOTUM
SCHEMBL19047038 0.81 OPRM1 (0.38) OPRM1OPRK1OPRL1OPRD1NOTUM
SCHEMBL10173839 0.76 MTNR1A (0.49) MTNR1AMTNR1BADRA2AADRA2BADRA2C
SCHEMBL13345363 0.76 MTNR1A (0.49) MTNR1AMTNR1BADRA2AADRA2BADRA2C
SCHEMBL20980913 0.76 MTNR1A (0.49) MTNR1AMTNR1BADRA2AADRA2BADRA2C
SCHEMBL19844808 0.75 MAOA (0.46) OPRM1OPRK1SLC6A2SLC6A4
SCHEMBL19368171 0.75 MTNR1A (0.56) MTNR1AMTNR1BPRKCGPRKCAPRKCD
SCHEMBL4798469 0.74 SLC6A2 (0.49) MTNR1AMTNR1BADRA2AADRA2BADRA2C
SCHEMBL1450544 0.74 MTNR1A (0.51) MTNR1AMTNR1BADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3119784-B1 BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER CAPELLA THERAPEUTICS INC (US) 2020-07-22 EP disclosed